Page 15 - Read Online

Julka et al. J Transl Genet Genom 2020;4:455-63 I http://dx.doi.org/10.20517/jtgg.2020.46 Page 463

com/static/ASCPResources/Press/store+pdfs/439XTableofContents%5B1%5D.pdf. [Last accessed on 6 Nov 2020]
5. Cheville J, Algaba F, Epstein JI, Lopez-Beltran A. Mesenchymal tumours. In WHO classification of tumours of the urinary system and
male genital organs. IARC, Lyon, France; 2016. Available from:https://www.yumpu.com/en/document/read/51835534/world-health-
organization-classification-of-tumours-pathology-and-. [Last accessed on 6 Nov 2020]
6. Tannenbaum M. Adenoid cystic or “salivary gland” carcinomas of prostate. Urology 1975;6:238-9.
7. Shen MM, Abate-Shen C. Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev 2010;24:1967-2000.
8. Rajasekhar VK, Studer L, Gerald W, Socci ND, Scher HI. Tumour-initiating stem-like cells in human prostate cancer exhibit increased
NF-kappaB signalling. Nat Commun 2011;2:162.
9. Srigley JR, Dardick I, Hartwick RW, Klotz L. Basal epithelial cells of human prostate gland are not myoepithelial cells: a comparative
immunohistochemical and ultrastructural study with the human salivary gland. Am J Pathol 1990;136:957-66.
10. McKenney JK, Amin MB, Srigley JR, et al. Basal cell proliferations of the prostate other than usual basal cell hyperplasia: a
clinicopathologic study of 23 cases, including four carcinomas, with a proposed classification. Am J Surg Pathol 2004;28:1289-98.
11. Grignon DJ, Ro JY, Ordonez NG, Ayala AG, Cleary KR. Basal cell hyperplasia, adenoid basal cell tumor, and adenoid cystic carcinoma
of the prostate gland: an immunohistochemical study. Hum Pathol 1988;19:1425-33.
12. Ho AS, Kannan K, Roy DM, et al. The mutational landscape of adenoid cystic carcinoma. Nat Genet 2013;45:791-8.
13. Iczkowski KA, Ferguson KL, Grier DD, et al. Adenoid cystic/basal cell carcinoma of the prostate: clinicopathologic findings in 19 cases.
Am J Surg Pathol 2003;27:1523-9.
14. Cohen RJ, Goldberg RD, Verhaart MJ, Cohen M. Adenoid cyst-like carcinoma of the prostate gland. Arch Pathol Lab Med 1993;117:799-
801.
15. Schmid HP, Semjonow A, Eltze E, Wortler K, Hertle L. Late recurrence of adenoid cystic carcinoma of the prostate. Scand J Urol Nephrol
2002;36:158-9.
16. Terris MK. The appearance of adenoid cystic carcinoma of the prostate on transrectal ultrasonography. BJU Int 1999;83:875-6.
17. Jakob JA, Kies MS, Glisson BS, et al. Phase II study of gefitinib in patients with advanced salivary gland cancers. Head Neck
2015;37:644-9.
18. Chau NG, Hotte SJ, Chen EX, et al. A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the
salivary glands: current progress and challenges in evaluating molecularly targeted agents in ACC. Ann Oncol 2012;23:1562-70.
19. Fayyad LM, Al-Jader KM, Al-Hawwari BA. Asynchronous adenoid cystic carcinoma of the prostate and transitional cell carcinoma of the
urinary bladder. Saudi Med J 2006;27:1060-2.
20. Majumder B, Baraneedharan U, Thiyagarajan S, et al. Predicting clinical response to anticancer drugs using an ex vivo platform that
captures tumour heterogeneity. Nat Commun 2015;6:6169.
21. Frankel K, Craig JR. Adenoid cystic carcinoma of the prostate. Report of a case. Am J Clin Pathol 1974;62:639-45.
22. Ahuja A, Das P, Kumar N, Saini AK, Seth A, Ray R. Adenoid cystic carcinoma of the prostate: case report on a rare entity and review of
the literature. Pathol Res Pract 2011;207:391-4.
23. Singh SK, Gnanasekharan M, Kumar S, Ganesamoni R, Bal A. Metastatic adenoid cystic carcinoma of prostate: is androgen deprivation
therapy beneficial. J Postgrad Med Edu Res 2014;48:43-5.
24. Sakai M, Martinez-Arguelles DB, Patterson NH, Chaurand P, Papadopoulos V. In search of the molecular mechanisms mediating the
inhibitory effect of the GnRH antagonist degarelix on human prostate cell growth. PLoS One 2015;10:e0120670.